Medical Device Companies Showcase Global Ambitions at China Medical Device Going Global Project Roadshow

June 30, 2023, byTianjin Municipal Bureau of CommerceGuidance,VB100, VCBeatHosted by,Tianjin Economic-Technological Development Area Administrative CommitteeSupported by the organizerThe 2nd China Medical Device Global Expansion ConferenceHeld at the InterContinental Yujiapu Hotel, concurrent events of the conference—Medical Device Global Expansion Project Promotion Conferencealso successfully held.

This promotion event aims to provide a public platform for high-quality Chinese enterprises and projects planning to expand overseas, showcasing their core competitiveness through high-quality presentations.

Participating Companies in This Roadshow:Tongyi Medical, Broncus Medical, Peixin Technology, USTC, Leida Medical, Life Shield Medical, Boshijian Medical, Zuo Dian, Kenuo Medical, C&D Zhixin Group. Meanwhile,Germany Trade & Invest (North Rhine-Westphalia), Business Finland, Quebec Government Office in Beijing (Investment Division), Embassy of Israel in China, Italian Trade AgencyRepresentatives from embassies and consulates also attended this project promotion conference.

Chen Xingang, General Manager of Tongyi Medical: "Forging a New Ecosystem for Pediatric and Adult Respiratory Medical Devices"

Respiration is vital to human health. Tongyi Medical is committed to building an ecosystem company integrating design, R&D, manufacturing, sales, and a focus on pediatric medical devices. Its product portfolio includes pediatric nebulizers, nebulizer masks, FeNO analyzers, and pulmonary function testers. Currently, the company’s products cover six provinces, two municipalities directly under the central government, and eight city-level branches in China, reaching 1,000 secondary and tertiary hospitals. Internationally, its products have been exported to more than 30 countries worldwide, including India, Pakistan, Vietnam, and Egypt, many of which are part of the Belt and Road Initiative.

Figure 1. Chen Xingang, General Manager of Tongyi Medical

Cheng Qi, CFO of Broncus Medical Holdings Co., Ltd.: “High Barriers and Comprehensive Coverage: Chinese Enterprises Set Global Technical Standards”

Severe pulmonary diseases such as lung cancer and chronic obstructive pulmonary disease (COPD) are major threats to human health. Broncus Medical provides an integrated solution for precise interventional diagnosis and treatment of pulmonary diseases. Its globally unique patented technology, BPTNA, enables access to the entire lung, laying the foundation for the treatment of lung cancer and other pulmonary conditions. Among the two global technical standards for pulmonary navigation, Broncus Medical pioneered one: optical navigation. Leveraging its leading pulmonary optical navigation platform, the R&D teams at Broncus Medical’s dual research centers in China and the United States have innovatively developed a series of therapeutic products, including RF2, the world’s only transbronchial lung radiofrequency ablation system, and InterVapor, the world’s only implant-free thermal vapor therapy system for severe COPD. Meanwhile, Broncus Medical’s clinical trials are being successfully conducted in multiple countries and regions worldwide, achieving regulatory approvals across various markets under its global framework. Currently, the company’s products are available in 33 countries across Europe, North America, Asia, Oceania, and Africa, including the United States, the United Kingdom, Germany, and France, with plans to expand its commercial footprint to more countries in the future.

Figure 2. Cheng Qi, Chief Financial Officer of Broncus Medical Holdings Limited

Yuan Jingxian, CEO of Suzhou Peixin Technology Co., Ltd.: "AI-Based Cardiac Valve Surgical Planning Using Medical Imaging"

CT imaging analysis is a mandatory step prior to Transcatheter Aortic Valve Replacement (TAVR) surgery, requiring physicians to utilize specialized medical software for image segmentation, reconstruction, and precise measurement of cardiac CT scans. This sector has long been dominated by foreign products, presenting high entry barriers. The company has developed a cardiac valve analysis and assessment system benchmarked against these international counterparts, which has been fully commercialized and now surpasses them in performance. The company also aims to expand into overseas markets and sincerely invites partners to join forces in promoting the global reach of China’s medical imaging AI industry.

Figure 3 Yuan Jingxian, CEO of Suzhou Peixin Technology Co., Ltd.

Hou Mingtao, Founder of USTC: “Empowering Scientific Experimental Research with AI Automation—The Smart Fully Automated Life Science Laboratory”

Traditional laboratories suffer from low accuracy, excessive reliance on manual operations, and poor safety performance. USTech is dedicated to empowering life science laboratories with automation and AI technologies, building intelligent, fully automated laboratories that are efficient, precise, safe, eco-friendly, and cloud-shareable. The company currently holds multiple patented products, including fully automated high-throughput parallel vacuum concentration systems and fully automated high-throughput liquid-liquid extraction systems, addressing unresolved challenges in the industry. In the future, it plans to extend its smart automation technologies to empower other industry applications, creating a new model for digital service industries.

Figure 4. Hou Mingtao, Founder of USTC

Liu Yang, Head of Overseas Operations at Raytium Medical: “Outstanding Domestically Produced Large-Scale Radiotherapy Equipment”

Radiotherapy systems, including photon beams, proton beams, and other particle beams, are currently important modalities for tumor treatment. With continuous technological innovation driven by scientific and technological advancements, domestic enterprises have achieved leapfrog development—from initial TPS and MLC to later IVS and BPS, and further to the latest 6D Couch and MBS. By gradually mastering core technologies and significantly improving product quality, these companies are poised to usher in a new era of prosperity for Chinese-made medical devices.

Figure 5 Liu Yang, Head of Raytix Medical's Overseas Operations

Yuan Boheng, CFO of LifeShield & LungShield: "LifeShield Medical: Rooted in China, Looking to the World"

LifeShield Medical is currently focusing on a "full-platform" layout in the field of life support, with its core products being three devices ranging from extracorporeal support to endovascular interventional therapy: an intervention-based left ventricular assist system and ECMO. As a Sino-German multinational medical device company, LifeShield aims to leverage over a decade of technical expertise accumulated by its German team, capitalize on Chinese financial advantages, list on China’s capital markets, and ultimately establish a foothold in the Chinese market while expanding into the European Union market.

Figure 6. Yuan Boheng, CFO of Life Shield & Lung Shield

Yu Lingzi, Senior Manager of Strategic Cooperation at Baishi Medical: “Intelligent Connected Oncology Treatment Solutions and Overseas Expansion Case Studies”

The incidence of new cancer cases is rising year by year, with significant pain points in radiotherapy and surgical interventions. Currently, artificial intelligence technology has expanded into multiple areas of cancer treatment. Smart oncology treatment solutions aim to enhance therapeutic efficacy and patient survival rates by leveraging advanced technologies and data analytics. These solutions primarily consist of two key components: smart radiotherapy solutions and smart surgical solutions. Boshijian Medical is committed to providing comprehensive support and decision-making bases for healthcare institutions and medical teams, while also offering commercial software development kits (SDKs) to equipment manufacturers.

Figure 7. Yu Lingzi, Senior Manager of Strategic Cooperation at Baishi Medical

Zdeer Partner Tai Yang: “Zdeer: Home Healthcare Solutions”

Amidst the increasingly severe aging of society and the growing prevalence of sub-health conditions, Zuodian focuses on technological healthcare and healthy living. It provides comprehensive healthcare solutions based on home scenarios, strategically arranging its product categories around the core needs of wellness, therapy, and care. Its product portfolio mainly includes in-ear hearing aids, massagers, and nebulizers, covering multiple aspects of medical care, technology, and daily life. Currently, its overseas markets are primarily concentrated in Japan and the United States, with plans to expand into more countries in the future.

Figure 8. Tai Yang, Zdeer’s Left Point Partner

Qin Sixia, Assistant to the General Manager of Kenuo Medical: “Introduction to Kenuo Medical and Product Overview of Dermatology and Other Areas”

Konno Medical is dedicated to the R&D, manufacturing, sales, and service of medical electronic products. Multiple products have been among the first in the industry to obtain CE and FDA certifications, and the company holds over 190 product patents. Its product portfolio spans dermatology and aesthetic medicine, obstetrics and gynecology, ophthalmology, and emergency monitoring, with a focus on high-value, high-quality, smart healthcare solutions. The company has currently established subsidiaries in the United States, Russia, and Singapore, while branches in Germany and Australia are under preparation. Konno Medical aims to deepen its presence in existing skin aesthetics offerings while accelerating the mass production and market launch of products in postpartum rehabilitation, ophthalmology, and otolaryngology.

Figure 9 Qin Sixia, Assistant to the General Manager of Konuo Medical

Xiong Hao, Deputy General Manager of C&D Zhixin Group: “C&D Zhixin’s Overseas Business Development Plan”

C&D Zhixin, a member enterprise of C&D Group, is primarily engaged in the distribution of high-value medical consumables, direct hospital sales, in vitro diagnostics (IVD), and life sciences businesses. The company has established an integrated national operational network spanning across China. In the future, it will collaborate with Chinese medical device manufacturers and service providers along the industrial chain to promote high-quality domestically produced medical devices to the global market, contributing to high-quality healthcare worldwide.

Figure 10. Xiong Hao, Deputy General Manager of Jianfa Zhixin Group

Setting Sail to Empower Global Expansion! We believe the successful hosting of this promotional conference for overseas medical device projects will inspire and provoke thought among innovators in China’s medical device sector, encouraging them to continue exploring international regulatory frameworks and sales models, thereby helping Chinese medical devices reach new heights in global markets!